Position in CRSP
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$23,509,949
-$24,058,740 QoQ
Shares Held
494,218
-45.5% QoQ
Ownership
0.512%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 76.1249084412142.ToString("F0")%
Shared 21.820330299584395.ToString("F0")%
None 2.0547612592014053.ToString("F0")%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. CRSP ranks #50 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in CRSP
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,509,949 | 494,218 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $47,568,689 | 907,107 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $56,840,246 | 877,029 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $44,637,509 | 917,712 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $31,891,042 | 937,145 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $37,285,765 | 947,301 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $38,739,988 | 824,606 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $51,317,544 | 950,149 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $63,460,706 | 931,055 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $48,793,820 | 779,454 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $39,934,166 | 879,801 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $39,930,752 | 711,271 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $34,362,810 | 759,735 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $31,496,064 | 774,811 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $42,416,068 | 649,060 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $26,734,302 | 439,926 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $15,063,983 | 239,987 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $19,630,126 | 259,041 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $17,312,213 | 154,670 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $23,607,123 | 145,822 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $16,906,687 | 138,750 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $16,481,832 | 107,647 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $8,502,591 | 101,657 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $7,423,371 | 101,012 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,752,648 | 88,485 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||